Literature DB >> 28364162

18F-FDG PET/CT in Erdheim-Chester disease.

Rosa Fernández López1, Irene Acevedo Báñez2, Manuel Beltrán Robles3, Isabel Borrego Dorado2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28364162     DOI： 10.1007/s00259-017-3685-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Zahir Amoura
Journal:  Curr Opin Rheumatol       Date:  2012-01       Impact factor: 5.006

2.  The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.

Authors:  F J García-Gómez; I Acevedo-Báñez; R Martínez-Castillo; J L Tirado-Hospital; J I Cuenca-Cuenca; V M Pachón-Garrudo; R M Álvarez-Pérez; R García-Jiménez; E Rivas-Infante; J S García-Morillo; I Borrego-Dorado
Journal:  Eur J Radiol       Date:  2015-04-30       Impact factor: 3.528

3.  Unusual carotid stenosis detected by F-18 FDG PET/CT.

Authors:  Kang-Ho Choi; Ja-Hae Kim; Joon-Tae Kim; Seong-Min Choi; Seung-Han Lee; Man-Seok Park; Byeong-Chae Kim; Myeong-Kyu Kim; Ki-Hyun Cho
Journal:  Eur Neurol       Date:  2013-04-26       Impact factor: 1.710

4.  [Erdheim-Chester disease].

Authors:  Francisco Javier García-Gómez; Irene Acevedo-Báñez; Eloy Rivas-Infante; Isabel Borrego-Dorado
Journal:  Med Clin (Barc)       Date:  2014-07-02       Impact factor: 1.725

5.  FDG PET images in a patient with Erdheim-Chester disease.

Authors:  Chrissa Sioka; Juvianee Estrada-Veras; Irinia Maric; William A Gahl; Clara C Chen
Journal:  Clin Nucl Med       Date:  2014-02       Impact factor: 7.794
  5 in total
  1 in total

1.  Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease.

Authors:  Luisa Chiapparini; Giulio Cavalli; Tiziana Langella; Anna Venerando; Giacomo De Luca; Sergio Raspante; Giorgio Marotta; Bianca Pollo; Giuseppe Lauria; Maria Giulia Cangi; Simonetta Gerevini; Andrea Botturi; Davide Pareyson; Lorenzo Dagna; Ettore Salsano
Journal:  J Neurol       Date:  2017-12-04       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.